Literature DB >> 3838543

Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.

W Seeger, G Stöhr, H R Wolf, H Neuhof.   

Abstract

In isolated rabbit lungs standardized amounts of edema were induced. Stimulation with the Ca ionophore A23187, leukotriene C4, Pseudomonas aeruginosa cytotoxin and human serum (activated complement) all resulted in protein leakage into the alveolar space with no change in the total phospholipid content. The pressure-volume characteristics of the lungs and the characteristics of the lavage surfactant (Wilhelmy balance) were markedly altered, correlating to the lavage protein content. The surfactant alterations were reproduced by addition of perfusion fluid protein to control surfactant in vitro. All changes were far less expressed or even missing in isolated lungs developing the same amount of edema due to omittance of proteins from the perfusion liquid. Different proteins added to control surfactant in the Wilhelmy balance showed a marked rank order of potency in interfering with surfactant function: immunoglobulins G and M and elastin less than albumin less than fibrinogen less than fibrin monomers. The fibrin monomer effect was reproduced by addition of thrombin to a surfactant fibrinogen mixture and was partly reversed by subsequent incubation with plasmin. In conclusion, high-permeability edema induced by different means results in alterations of lung mechanics and surface activity of lavaged surfactant, presumably due to protein surfactant interaction. Among different proteins, fibrin monomers are especially effective in interfering with surfactant function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838543     DOI: 10.1152/jappl.1985.58.2.326

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  54 in total

1.  A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants.

Authors:  H E Warriner; J Ding; A J Waring; J A Zasadzinski
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

Review 2.  Coagulation-dependent mechanisms and asthma.

Authors:  Michael A Matthay; John A Clements
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

3.  Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

Authors:  N S Morton
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 4.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits.

Authors:  M Gupta; J M Hernandez-Juviel; A J Waring; F J Walther
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 6.  Ventilation and secretion of pulmonary surfactant.

Authors:  H Wirtz; M Schmidt
Journal:  Clin Investig       Date:  1992-01

7.  Computational Models of Ventilator Induced Lung Injury and Surfactant Dysfunction.

Authors:  Jason H T Bates; Bradford J Smith; Gilman B Allen
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

8.  Effects of exogenous surfactant on the non-heart-beating donor lung graft in experimental lung transplantation - a stereological study.

Authors:  Gudrun Herrmann; Lars Knudsen; Navid Madershahian; Christian Mühlfeld; Konrad Frank; Parwis Rahmanian; Thorsten Wahlers; Thorsten Wittwer; Matthias Ochs
Journal:  J Anat       Date:  2014-02-14       Impact factor: 2.610

9.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.

Authors:  Peter Dahlem; Albert P Bos; Jack J Haitsma; Marcus J Schultz; Joost C M Meijers; Burkhard Lachmann
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.